+ All Categories
Home > Documents > PHRM 3050 Fall 2014 Course Packet

PHRM 3050 Fall 2014 Course Packet

Date post: 11-Oct-2015
Category:
Upload: miliuel
View: 71 times
Download: 0 times
Share this document with a friend
Description:
Fall course packet
Popular Tags:

of 99

Transcript
  • PHRM 3050

    The Biochemical Basis of Disease and Drug Action

    Michael G. Bartlett, Ph.D.

  • PHRM 3050 Fall 2014

    The Biochemical Basis of Disease and Drug Action

    Instructor: Michael G. Bartlett, Ph.D. Office: RC Wilson Room 420

    Class: M 11:15-12:05, W 10:10-12:05 Phone: 542-5390

    Room: 120 College of Pharmacy E-mail: [email protected]

    The purpose of this course is to train you in biochemistry. Biochemistry is the basis of

    physiological function, which determines the pharmacology of drugs. It is the basis of

    chemotherapy for infectious diseases where the biochemical differences of the infectious

    agents (bacteria, fungi, protozoa and virus) are exploited in order to bring about the death

    of the organism without affecting the host. It is the basis of the chemotherapy for cancer

    where the biochemical differences between the cancer cell and the normal cell are

    exploited to bring about cell death. Finally, it is the basis of some pharmacotherapies

    where the target of the drug is an enzyme, which is inhibited. The importance of

    knowledge of biochemistry in the understanding of diseases, of how drugs work, the role

    of vitamins and minerals in metabolism and the rational selection of pharmacotherapies

    cannot be over emphasized.

    Method of Evaluation

    There will be 3 hourly exams during the semester plus a comprehensive final exam

    during finals week, each will count 24% of your final grade. These may consist of a

    combination of multiple choice, multiple-multiple choice (keyed questions), short answer,

    numerical problems and essay questions. You are expected to know the names of

    enzymes, the structure and name of the substrates, the products of enzymatic reactions

    and the name and structure of any known inhibitors of the process.

    Exam Dates

    Exam I 8 am, Monday September 15th

    , 2014

    Exam II 8 am, Friday September 26th

    , 2014

    Exam III 8 am, Friday October 17th

    , 2014

    Final Exam 8 am, Monday November 11th

    , 2014

    The remaining four percent of your grade will be determined by your completion of

    minute papers assigned throughout the semester. Minute papers are used to quickly

    determine the impact of any lecture and to allow the instructor make adjustments to the

    course prior to examinations. For these papers, you are asked to answer three questions:

    1) What is the most significant fact that you learned today; 2) What is the most unclear

    point from todays lecture; and 3) What is the most interesting point from todays lecture.

    The minute paper is a pass/fail type of assignment with no correct or incorrect answers.

    The class is divided into four laboratory sections for skills labs. One section will be

    responsible for turning in a paper each day. Therefore, each student should only have to

    turn in a minute paper once every two weeks.

  • Grading Scale for PHRM 3050

    Grade %

    A 92.00-100

    A- 89.50-91.99

    B+ 87.00-89.49

    B 82.00-86.99

    B- 79.50-81.99

    C+ 77.00-79.49

    C 72.00-76.99

    C- 69.50-72.00

    D 59.50-69.49

    F 0.00-59.49

    Regrading Policy

    Students who believe that an error has occurred in the grading of an assignment should

    alert the instructor within two weeks of the date of the assignment. Additional points

    may be awarded at the discretion of the instructor. No grades will be changed once the

    two-week period for regrading has passed.

    Make-Up Examination Policy

    Students may be permitted to take a make-up examination under the following

    conditions. 1) The student was medically unable to be in school and appropriate proof is

    provided to the instructor. 2) There is a conflict with another University or College

    academic function and the student has informed the instructor at least 48 hours prior to

    the examination. 3) Other personal emergencies will be handled on a case-by-case basis.

    Make-up tests will not contain any multiple choice questions and will be primarily essay

    in nature. The examinations may take longer than the time normally allotted for standard

    assignments. Make-up examinations must occur within a week of the original test date or

    the student will receive a zero for the assignment.

    Calculator Policy

    Calculators may be permitted on some exams. During the exams, only basic scientific

    calculators with simple functions such as addition, subtraction, multiplication, division,

    logarithms and exponents will be allowed. Examples of acceptable calculators are the

    Casio 100-300, Sharp 500 and TI-30 series. The instructor must approve other

    calculators 24 hours before the exam begins. Calculators with graphing and

    differentiating capabilities are NOT allowed. Use of calculators on cell phones or PDAs

    is NOT allowed. Use of an unauthorized calculator will result in a zero for the

    examination and will be considered a violation of the UGA academic honesty policy and

    the College of Pharmacy Professionalism Policy.

  • Class Attendance and Absences

    Students are expected to attend class regularly. A student who incurs an excessive

    number of absences may be dismissed from a class at the discretion of the instructor. If

    the student must miss an exam due to illness or another emergency, the instructor should

    be informed, either directly or through the Deans office, of the situation prior to the

    exam being given. The student will then be given a make-up exam as soon as possible

    after the student returns to class. An unexcused absence from an exam will result in a

    zero for that exam at the discretion of the instructor.

    Academic Honesty

    The University of Georgia Honor Code, Academic Policy and the College of Pharmacy

    Professionalism Policy provide the framework for all assignments and interactions

    associated with this course. In addition, all academic work must meet the standards

    contained in "A Culture of Honesty." Students are responsible for informing themselves

    about those standards before performing any academic work.

    Texts

    Harpers Illustrated Biochemistry, 29th Edition by Murray, Bender, Botham, Kennelly,

    Rodwell and Weil.

    Supplemental Reading Sources

    Biochemistry by Berg, Tymoczko and Stryer

    Medical Biochemistry by Bhagavan

    Principles of Biochemistry with a Human Focus by Garrett and Grisham

    Biochemistry by Garrett and Grisham

    Medicinal Chemistry Edward Foye

    Textbook of Biochemistry with Clinical Correlations by Thomas Devlin

    Biochemistry by Donald and Judith Voet

    The Pharmacological Basis of Therapeutics by Goodman and Gilman

    Biochemistry and Disease by Cohn and Roth

  • Topical Outline of Material to be Covered

    I. Characteristics of Proteins (Ch. 3-5)

    A. Amino Acids

    B. Peptide Bond

    C. Protein Structure and Function

    II. The Role of Enzymes in Biochemical Processes (Ch. 7-9)

    A. Regulation of Enzymes

    B. Catalytic Properties of Enzymes

    C. Enzyme-Substrate Interactions

    D. The Active Site of an Enzyme

    E. Enzyme Kinetics (Michaelis-Menten)

    F. Enzyme Inhibition Mechanisms

    G. Enzyme Regulation

    III. The Metabolism of Carbohydrates (Ch. 14)

    A. Glycolysis (Ch. 18)

    B. Gluconeogenesis (Ch. 20)

    C. The Tricarboxylic Acid Cycle (Ch. 17)

    D. Electron Transport Chain & Ox. Phos. (Ch. 13)

    IV. Storage and Retrieval of Glucose (Ch. 19)

    A. Glycogen Formation

    B. Glycogen Metabolism

    V. The Metabolism of Lipids (Ch. 15, 22, 25)

    A. Lipids as an Energy Source and Energy Storage

    1. Nomenclature

    2. Cell Membranes

    B. Mobilization of Fatty Acids

    C. Fate of Glycerol

    D. -Oxidation

    1. Saturated Fatty Acids

    2. Unsaturated Fatty Acids

    E. Diabetes Mellitus

    VI. Metabolism of Amino Acids (Ch. 28-30)

    A. Essential versus Non-essential Amino Acids

    B. Metabolic Fate of Amino Acids

    C. Pyridoxal Phosphate

    D. Urea Cycle

    E. Utilization of Amino Acids for the Synthesis of Other Biomolecules

    1. Neurotransmitters

    a. Acetylcholine, Dopamine, Norepinephrine,

    Serotonin, GABA

  • b. Phenylketouria

    2. Autocoids and Hormones

    a. Histamine, Thyroxin, Epinephrine

    3. Creatine, Phosphocreatine, Creatinine

    4. Heme, Bilirubin, Jaundice

    VII. One Carbon Transfers (Ch. 30)

    A. Tetrahydrofolic Acid and One-Carbon Unit Transfers.

    B. Folic Acid Pathway

    C. S-Adenosylmethionine (SAM) and Methyl Group Transfers.

    D. The Active Methyl Cycle.

    VIII. Biosynthesis & Metabolism of Nucleotides and Nucleosides (Ch. 32-33)

    A. De Novo Synthesis

    1. Pyrimidine Nucleotides

    2. Purine Nucleotides

    B. Salvage Pathway

    1. Pyrimidines

    2. Purines

    3. Metabolic Defects in Purine and Pyrimidine Metabolism

    4. Targets for Chemotherapeutic Intervention

    IX. Vitamins, Cofactors for Metabolism (Ch. 44 and Handout)

    A. Water Soluble Vitamins

    1. The B Complex Vitamins

    2. Vitamin C

    B. Fat Soluble Vitamins

    Note: The course syllabus is a general plan for the course; deviations announced to the

    class by the instructor may be necessary.

  • o-

    o-

    o-

    o O

    M

    to

    O=

    O o

    l O

    -O

    J-

    O-

    O-

    O X

    I

    I

    I

    0

    =0

    o

    tit

    tO o

    o

    0=0 o

    x-

    o I

    I 0=

    0 o

    0>

    2

    O-

    O-

    O-

    O-

    O +

    I I

    I I

    X M

    IO

    N>

    K>

    I 0

    =0

    o

    I

    \\ l O

    -O

    -O

    0=

    0 O

    l O

    -O

    -O

    X

    XX

    0

    =0

    o

    l 0

    -0

    X

    X

    0

    I 0=

    0

    I I

    \ l p

    z

    -0

    -0

    -0

    -0

    //

    I I

    X I

    X X

    10

    +

    \\ l + 0

    0

    0

    -0

    o

    1 0=

    0 o

    X w

    o l -

    o X

    I 0

    =0

    o

    o

    o

    0=

    0

    o

    z W

    M O

    -O

    -O

    0=

    0 o

    l co

    -0-0

    to

    0=

    0 o

    XX

    IO

    I 0=

    0

  • redu

    ctio

    n

    oxid

    atio

    n

    OH

    OH

    FAD

    FADH

    2

    00

    HO

    OH

    H2N

    redu

    cUon

    oxid

    atio

    n

    HQ

    vv

    H2

    N

    OH

    I o

    NAD*

    NA

    DH

  • ATP

    ADP

    hexo

    kina

    se

    OH Gl

    ucos

    c-6-

    phos

    phal

    e

    O II O

    -P

    -

    phos

    phog

    luco

    se is

    omei

    ase

    .OH

    'OH

    ATP

    ADP

    I Fr

    ucto

    sc-6

    -pho

    spha

    te

    6-ph

    osph

    ofru

    cto-

    1 -ki

    nasc

    O O-

    R

    OH fn

    icto

    se-1

    ,6-b

    ipho

    spha

    le (F

    BP)

    Prim

    ing s

    tage

    o-p-

    o.

    .O-P

    -O O

    R H

    O-

    OH

    fruc

    tose

    -1.6

    -bip

    hosp

    hale

    (F

    BP)

    hcmi

    keta

    l fur

    anos

    e for

    m

    Clea

    vage

    Stag

    e

    Glyc

    etal

    dehy

    de 3-

    phos

    phai

    c (G

    AP)

    I

    GAP

    Dehy

    drog

    cnas

    e OH

    O O-

    P-O 6 Gl

    ycer

    alde

    hyde

    3-ph

    osph

    ale (G

    AP)

    Ott

    -O

    P-0

    Phos

    phog

    lyce

    rale

    ki

    nase

    \

    NAD+

    NA

    DH

    o 1,

    3-Bi

    phos

    phog

    lyce

    ratc

    (1

    .3-B

    GA)

    ADP

    ATP

    -0

    -IO

    H O

    3-ph

    osph

    ogly

    cera

    le (3

    -PGA

    )

    Phos

    phog

    lycc

    ratc

    Mu

    tase

    Ener

    gy Pr

    oduc

    tion

    stag

    e

    X

    0-

    O

    1 OH

    O 2-

    phos

    phog

    lyce

    rate

    (2

    -PGA

    ) eno

    lase

    H20

    ~-c-o

    . ""in

    , L-

    Laci

    ale

    Laci

    ale d

    ehyd

    roge

    nase

    h CH, Py

    niva

    te

    *C-O- I

    NAD+

    NA

    DH

    Pymv

    ate

    Kina

    se

    ATP

    ADP

    Phosph

    ocnolp

    yruvat

    e (P

    EP)

  • -10-

    Galactose Metabolism CHjOH

    OH -O H ATP ADP CHjOH

    H OH

    Galactose

    Galactokinase oh h

    0POjJ

    H OH Galactose-1 -phosphate

    CHjOH

    OH

    CH2OH

    UDP-Glucose

    OH H

    | H OH

    UDP-Galaetose

    OPOjJ Galactose-1-phosephate CH0H Uridyl Transferase H oh

    Galactose-1 -phosphate

    OPOj3

    CHjOH

    OH

    Glucose-1 -phosphate

    CHjOH

    OH H

    0. H

    UOP UDP-Galactose 4-Epimerase OH

    H OH

    UDP-Galactose

    UDP

    H oh

    UDP-Glucose

    CHjOPOj'

    Phosphoglucomutase OPO,J

    OH H

    OH

    H OH

    Glucose-1 -phosphate

    OH

    H OH

    Glucose-6-phosphate

  • Fructose Metabolism

    CH2OH CH2OH ATP HO

    CH2OH CH2OPO3 -2

    OH Fructokinase

    HO

    OH

    OH Fructose

    OH

    Fructose-1 -phosphate

    CH2OH CH2OPO3-2

    HO.

    OH Fructose-1 -phosphate Aldolase

    -opo,-2

    :O

    OH

    CHO

    OH

    CH2OH

    OH

    Fructose-1 -phosphate Dihydroxyacetone phosphate Glyceraldehyde

    CHO ATP ADP

    -OH

    CHO

    CH2OH Triose Kinase -OH

    -OPO,"2

    Glyceraldehyde Glyceraldehyde-3 -phosphate

  • COj

    NADH

    Dihy

    drol

    ipoy

    l Deh

    ydro

    geiu

    se

    NAD*

    TPP=

    thim

    ninc

    pyro

    phos

    plul

    c Li

    ps L

    tpoa

    miJe

    Co

    A-SH

    = C

    ocru

    ymc

    A

    Acet

    yl C

    oA's

    abili

    ty to

    ente

    r the

    TCA

    cycl

    e de

    pend

    s on

    the c

    once

    ntra

    tion

    and

    availa

    bility

    of Ox

    aloa

    ceta

    te. Wh

    en ca

    rboh

    yrat

    es in

    take

    is lo

    w, as

    in fa

    sting

    or sta

    rvatio

    n, or

    impr

    oper

    ly ut

    ilized

    as in

    Diab

    etes

    . Ox

    aloa

    ceta

    te is

    unav

    aila

    ble t

    o mak

    e th

    e cyc

    le run

    . Ace

    tyl C

    oA u

    nder

    goes

    anot

    her f

    ate

    COO"

    NADH

    Mala

    te De

    hydr

    ogen

    ase

    FADH

    2

    N3 I

    coo-' S

    ucdn

    yl C

    oA S

    ynth

    etas

    e | CH

    2 H

    IH

    GTP

    -C-S

    CoA

    Succ

    inyl

    CoA

    COO"

    CH2 H

    JH O

    :=

    C CO

    O" a-

    Kelo

    gluu

    rale

    a-

    Keto

    glul

    arat

    e Deh

    ydro

    gena

    se

    CO2 NA

    DH

  • Elec

    tron

    Tran

    spor

    t Cha

    in

    NADH

    -CoE

    nzym

    e Q

    CoEn

    zyme

    Q -

    Cyt

    C Re

    duct

    ase

    Redu

    ctas

    e N

    AD

    H

    NADH

    Fatt

    y Acy

    l Co

    A De

    hydr

    ogen

    ase (F

    AD)

    Cyto

    chro

    me C

    Ox

    idas

    e

    CytC

    CytC

    Gly c

    erol

    -3 -p

    hosp

    hate

    De

    hydr

    ogen

    ase (F

    AD)

    Succ

    inyl

    Deh

    ydro

    gena

    se (F

    AD)

    H2O

  • Oxid

    ativ

    e Pho

    spho

    ryla

    tion

    Ma

    trix

    AT

    P Sy

    ntha

    se

    ADP

    + Pi

    AT

    P

    Comp

    lex

    I Co

    mple

    x III

    Co

    mple

    x IV

    H+

    H+

    H+

    IMS

    HH

    Cyto

    sol

  • PHRM 3050 Fall 2014 Course PacketPHRM 3050 Syllabus 2014PHRM 3050 Fall 2013 Course PacketPHRM 3050 Syllabus 2013PHRM 3050 Fall 2012 Course PacketPHRM 3050 Syllabus 2012.pdfPHRM 3050 Fall 2012 Course PacketPHRM 3050 Syllabus 2012.pdfPHRM 3050 Fall 2012 Course PacketPHRM 3050 Syllabus 2012.pdfPHRM 3050 Fall 2011 Course PacketPHRM 3050 1.pdfPHRM 3050 2PHRM 3050 3PHRM 3050 4PHRM 3050 5

    PHRM 3050 2011 Test 1PHRM 3050 2012 Test 1PHRM 3050 2011 Test 2PHRM 3050 2012 Test 2PHRM 3050 2011 Test 3PHRM 3050 2012 Test 3

    PHRM 3050 2013 Test 1PHRM 3050 2013 Test 2PHRM 3050 2013 Test 3


Recommended